<DOC>
	<DOCNO>NCT01525615</DOCNO>
	<brief_summary>The primary objective study compare effect orally inhale tiotropium + olodaterol fix dose combination ( 2.5/5 µg ; 5/5 µg ) placebo exercise tolerance 12 week treatment patient COPD .</brief_summary>
	<brief_title>A Study Determine Effect Tiotropium + Olodaterol Fixed Dose Combination Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : 1 . All patient must sign informed consent consistent ICHGCP guideline prior participation trial , include medication washout restriction . 2 . All patient must diagnosis chronic obstructive pulmonary disease must meet follow spirometric criterion : Patients must relatively stable airway obstruction , visit 1 : postbronchodilator 30 % &lt; = FEV1 &lt; 80 % predict normal ( ECSC ) postbronchodilator FEV1/FVC &lt; 70 % Visit 1 3 . Male female patient , 40 75 year ( inclusive ) age day sign informed consent . 4 . Patients must current exsmokers smoke history 10 pack year Patients never smoke cigarette must exclude . 5 . Patients must able perform technically acceptable pulmonary function test ( spirometry ) , must able complete multiple symptomlimited cycle ergometry test ( subset also shuttle walk test ) , require protocol . 6 . Patients must able inhale medication competent manner RESPIMAT inhaler meter dose inhaler ( MDI ) . Exclusion criterion : 1 . Patients significant disease COPD 2 . Patients clinically relevant abnormal baseline haematology , blood chemistry , urinalysis ; patient SGOT &gt; x2 ULN , SGPT &gt; x2 ULN , bilirubin &gt; x2 ULN creatinine &gt; x2 ULN exclude regardless clinical condition 3 . Patients history asthma 4 . A diagnosis thyrotoxicosis 5 . A diagnosis paroxysmal tachycardia ( &gt; 100 beat per minute ) 6 . A history myocardial infarction within 1 year screen visit ( Visit 1 ) 7 . Unstable lifethreatening cardiac arrhythmia 8 . Hospitalized heart failure within past year 9 . Known active tuberculosis 10 . A malignancy patient undergone resection , radiation therapy chemotherapy within last five year 11 . A history lifethreatening pulmonary obstruction patient chronic respiratory failure 12 . A history cystic fibrosis 13 . Clinically evident bronchiectasis 14 . A history significant alcohol drug abuse 15 . Any contraindication exercise test 16 . Patients undergone thoracotomy pulmonary resection 17 . Patients treat oral ßadrenergics 18 . Patients treat oral corticosteroid medication unstable dos ( i.e. , less six week stable dose ) dose excess equivalent 10 mg prednisone per day 20 mg every day 19 . Patients regularly use daytime oxygen therapy one hour per day investigator 's opinion unable abstain use oxygen therapy clinic visit 20 . Patients complete pulmonary rehabilitation program six week prior screen visit ( Visit 1 ) patient currently pulmonary rehabilitation program 21 . Patients limitation exercise performance result factor fatigue exertional dyspnoea morbid obesity 22 . Patients endurance time &gt; =25 minute train ( Visit 2 ) baseline ( Visit 3 ) constant work rate cycle ergometry 23 . Patients take investigational drug within one month six half life ( whichever great ) prior screen visit ( Visit 1 ) 24 . Patients know hypersensitivity ßadrenergic drug , anticholinergic drug , BAC , EDTA component RESPIMAT inhalation solution delivery system 25 . Pregnant nursing woman 26 . Women childbearing potential use highly effective method birth control . Female patient consider childbearing potential unless surgically sterilise hysterectomy bilateral tubal ligation , postmenopausal least two year 27 . Patients previously randomize study currently participate another study 28 . Patients unable comply pulmonary medication restriction prior randomization At site perform shuttle walk test , patient follow criterion exclude shuttle walk test : 29 . Patients complete level 12 incremental shuttle walk test visit 1a . 30 . Patients endurance time &gt; =15 minute train ( Visit 2a ) baseline ( visit 3a ) endurance shuttle walk test .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>